Several biomedical analyses are performed on particular types of cells present in body
samples or using functionalized microparticles. Success in such analyses depends on the …

Detecting cancer biomarkers (eg, circulating tumor cells, extracellular vehicles, nucleic
acids, and protein biomarkers) is vital for risk assessment and early diagnosis. Nanomaterial …

The selection of circulating tumor cells (CTCs) directly from blood as a real-time liquid
biopsy has received increasing attention over the past ten years, and further analysis of …

Separation of micro-and nano-sized bioparticles is essential for efficient diagnostics,
chemical and biological analyses, drug development, food and chemical processing, and …

Cancer remains the leading cause of death worldwide despite the enormous efforts that are
made in the development of cancer biology and anticancer therapeutic treatment …

Cell separation has consistently been a pivotal technology of sample preparation in
biomedical research. Compared with conventional bulky cell separation technologies …

CTCs (circulating tumor cells) are well-known for their use in clinical trials for tumor
diagnosis. Capturing and isolating these CTCs from whole blood samples has enormous …

Extreme rarity and inherent heterogeneity of circulating tumor cells (CTCs) result in a
tremendous challenge for the CTC isolation from patient blood samples with high efficiency …

Disease diagnostics, food safety monitoring and environmental quality monitoring are the
key means to safeguard human health. However, conventional detection devices for health …

Circulating tumor cells (CTCs) are the cancer cells that circulate in the peripheral blood after
escaping from the original or metastatic tumors. CTCs could be used as non-invasive source …